Pub. Date : 2017 Sep
PMID : 28782884
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Patients with a del(17p) or TP53 mutation can be treated with ibrutinib, venetoclax, or a combination of idelalisib and rituximab. | ibrutinib | tumor protein p53 | Homo sapiens |